title: Reply: Lysosomal dysfunction in Parkinson's disease.
authors.affiliation: 1 Neuroscience Research Australia, Sydney, NSW 2031, Australia 2 School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia g.halliday@neura.edu.au.
authors.forename: Glenda M
authors.initials: GM
authors.lastname: Halliday
authors.affiliation: 1 Neuroscience Research Australia, Sydney, NSW 2031, Australia 2 School of Medical Sciences, Faculty of Medicine, The University of New South Wales, Sydney, NSW 2052, Australia.
authors.forename: Karen E
authors.initials: KE
authors.lastname: Murphy
mesh_terms: D005260:Female; D005962:Glucosylceramidase / Q000037:antagonists & inhibitors*; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000378:metabolism*; D015854:Up-Regulation / Q000502:physiology*; D051844:alpha-Synuclein / Q000096:biosynthesis*
chemical_list: D051844:alpha-Synuclein; D005962:Glucosylceramidase